Morgan Stanley’s Enlivex Ltd ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.5K Sell
6,556
-6,819
-51% -$108K ﹤0.01% 6204
2025
Q4
$141K Buy
13,375
+1,800
+16% +$26.8K ﹤0.01% 6062
2025
Q3
$181K Sell
11,575
-3,035
-21% -$54.7K ﹤0.01% 5927
2025
Q2
$245K Sell
14,610
-769
-5% -$11.4K ﹤0.01% 5772
2025
Q1
$224K Sell
15,379
-2,598
-14% -$43.2K ﹤0.01% 5686
2024
Q4
$315K Buy
17,977
+1,593
+10% +$31K ﹤0.01% 5613
2024
Q3
$413K Buy
16,384
+58
+0.4% +$1.18K ﹤0.01% 5489
2024
Q2
$348K Buy
16,326
+11,518
+240% +$306K ﹤0.01% 5453
2024
Q1
$273K Sell
4,808
-1,120
-19% -$54.7K ﹤0.01% 5602
2023
Q4
$240K Buy
5,928
+2,984
+101% +$76K ﹤0.01% 5876
2023
Q3
$69.8K Buy
2,944
+21
+0.7% +$727 ﹤0.01% 6028
2023
Q2
$115K Buy
2,923
+246
+9% +$10.3K ﹤0.01% 5886
2023
Q1
$146K Sell
2,677
-38
-1% -$2.29K ﹤0.01% 5846
2022
Q4
$160K Sell
2,715
-253
-9% -$16.3K ﹤0.01% 5758
2022
Q3
$189K Buy
2,968
+786
+36% +$57.4K ﹤0.01% 5750
2022
Q2
$148K Buy
2,182
+744
+52% +$57.6K ﹤0.01% 6045
2022
Q1
$121K Buy
1,438
+294
+26% +$23.8K ﹤0.01% 6201
2021
Q4
$107K Sell
1,144
-92
-7% -$10.8K ﹤0.01% 6400
2021
Q3
$183K Buy
1,236
+296
+31% +$43.4K ﹤0.01% 6050
2021
Q2
$126K Sell
940
-95
-9% -$14.3K ﹤0.01% 6247
2021
Q1
$172K Buy
1,035
+848
+453% +$175K ﹤0.01% 5747
2020
Q4
$24K Buy
+187
New +$30.1K ﹤0.01% 6375
2020
Q3
Hold
0
6755
2020
Q2
Sell
-1,877
Closed -$151K 6632
2020
Q1
$132K Buy
+1,877
New +$207K ﹤0.01% 5067
2019
Q4
Hold
0
6677
2019
Q3
Hold
0
6667
2019
Q2
Hold
0
6671
2019
Q1
Hold
0
6616
2018
Q4
Sell
-4
Closed -$1K 6624
2018
Q3
$1K Buy
+4
New +$639 ﹤0.01% 6621
2017
Q3
Sell
-1
Closed 6549
2017
Q2
$0 Buy
+1
New +$303 ﹤0.01% 6602
2017
Q1
Sell
-1
Closed -$1K 6582
2016
Q4
$1K Hold
1
﹤0.01% 6430
2016
Q3
$1K Hold
1
﹤0.01% 6415
2016
Q2
$1K Buy
+1
New +$1.24K ﹤0.01% 6420
2016
Q1
Hold
0
6612
2015
Q2
Sell
-1
Closed -$4K 6668
2015
Q1
$4K Buy
+1
New +$4.29K ﹤0.01% 6368
2014
Q4
Hold
0
6587
2014
Q3
Hold
0
6586

Other funds holding ENLV

Morgan Stanley's ENLV Position: Q1 2026 in Review

Morgan Stanley reduced its Enlivex Ltd (ENLV) stake by 51% in Q1 2026, selling an estimated $108K and leaving 6,556 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6204.

Morgan Stanley first reported a position in ENLV in Q1 2015 and has held it in 29 quarters since. The position peaked at $413K in Q3 2024. 34 funds tracked by Wall St. Rank hold ENLV as of Q1 2026.

  • Morgan Stanley held 6,556 shares of Enlivex Ltd worth $91.5K as of Q1 2026.
  • Morgan Stanley sold 6,819 Enlivex Ltd shares in Q1 2026, an estimated $108K.
  • Enlivex Ltd made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6204 holding.
  • Morgan Stanley first reported a position in Enlivex Ltd in Q1 2015 and has held it in 29 quarters since.
  • Morgan Stanley's Enlivex Ltd position peaked at $413K in Q3 2024.
  • 34 funds tracked by Wall St. Rank held Enlivex Ltd as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.